Company Overview
Snapshot
Founded in January 2024 by Yonatan Hayoun, Saforax operates with 1–10 employees. The company is currently in the Pre-Funding stage, developing an innovative medical device for chest drainage procedures.
Business overview
Saforax is a Health Tech & Life Sciences company focused on developing an innovative medical device, Saforax (Safe-for-Thorax), to transform chest drainage procedures. This technology aims to make chest decompression accessible at the point of injury for lower-skilled practitioners, including those in high-stress environments like battlefields. The company targets the global chest drainage devices market, addressing critical needs in trauma care for both military and civilian settings, with its minimally invasive design promoting faster recovery and reduced complications. Saforax operates within the Medical Devices sector, serving the healthcare, military, and emergency response industries.
Log in to access full profile ›Company Intelligence Q&A
- What is Saforax's primary product?
- Saforax's primary product is an innovative medical device called Saforax (Safe-for-Thorax), designed to simplify and improve chest drainage procedures.
- When was Saforax founded?
- Saforax was founded in January 2024.
- Who is a founder of Saforax?
- Yonatan Hayoun is a founder of Saforax, serving as the CTO.
- What market need does Saforax address?
- Saforax addresses the critical need for rapid and safe intervention in chest injuries, which are a leading cause of preventable death in combat, by enabling lower-skilled practitioners to perform chest decompression effectively.
- What is the current stage of Saforax's product development?
- Saforax's product, Saforax (Safe-for-Thorax), is currently in the R&D stage, with preliminary results indicating it is safe and allows for alternative placement outside traditional anatomical "safe zones." The company aims to set a new benchmark for trauma care and chest tube insertion.